Company Overview of Akermin, Inc.
Akermin, Inc., a biocatalyst development company, develops a solution to remove carbon dioxide (CO2) from industrial gas streams using biocatalysis and nanotechnology. The company offers proprietary delivery systems to integrate enzymes into conventional processes for CO2 removal using chemical absorption. Its technology serves a range of industries and markets in the United States. The company was founded in 2003 and is based in St. Louis, Missouri.
1005 North Warson Road
St. Louis, MO 63132
Founded in 2003
Key Executives for Akermin, Inc.
Akermin, Inc. Key Developments
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact Akermin, Inc., please visit akermin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.